Concepedia

Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy

Everett Stone, Lynne Chantranupong, Candice Gonzalez, Jamye F. O’Neal, Mridula Rani, Carla L. VanDenBerg, George Georgiou

Journal of Controlled Release · 2011 · 27 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Modeling of the Bacterial Growth Curve

M.H. Zwietering, I. Jongenburger, F.M. Rombouts et al. · Applied and Environmental Microbiology · 1990 · 4.2K citations · Full text

, , +13

Body condition scoring: a rapid and accurate method for assessing health status in mice.

Mollie Ullman-Culleré, C J Foltz · PubMed · 1999 · 566 citations

, , +11

A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner

Volker Schellenberger, Chia‐Wei Wang, Nathan C. Geething et al. · Nature Biotechnology · 2009 · 460 citations

, , +4

FDA Drug Approval Summary: Pegaspargase (Oncaspar®) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL)

Patricia A. Dinndorf, Joseph E. Gootenberg, Martin H. Cohen et al. · The Oncologist · 2007 · 323 citations

, , +14

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

Mark Ensor, Frederick W. Holtsberg, John S. Bomalaski et al. · PubMed · 2002 · 319 citations

, , +15